Tag: Biopharmaceuticals

Longeveron is the short squeeze Reddit Apes can give thanks for this year

Short sellers really should have thought twice before betting huge against a company literally named Longeveron LGVN, +145.64%. Retail investors have struck again, executing another short squeeze of a relatively anonymous stock, pushing Longeveron shares up another 145.6% on Wednesday to bring its five-day gain to 1,000%-plus as short interest in the stock fell, indicating […]

Read More

Celltrion shares rally in South Korea after EU OKs marketing of its COVID-19 treatment

Celltrion Inc.’s shares rallied Monday after the European Commission granted the South Korean biotech firm approval to market its COVID-19 antibody treatment. The European approval of Regdanvimab, marketed by Celltrion as Regkirona in South Korea, drop up the company’s stock price 068270, +9.13% as much as 18% to 251,000 Korean won ($212.72) after the news […]

Read More

Merck nears deal for rare-disease-drug maker Acceleron

Merck is in advanced talks to acquire Acceleron Pharma Inc., according to people familiar with the matter, in a move that would bolster the pharmaceutical giant’s rare-disease business. The deal for Acceleron, which has a market value of around $11 billion, could be announced this week, assuming talks don’t fall apart, the people said. Source […]

Read More

Delta Air Lines to impose $200 monthly surcharge for unvaccinated employees in health care plan

Delta Air Lines Inc. DAL, +1.32% is stepping up efforts to get employees vaccinated against Covid-19, introducing measures including weekly testing requirements and a monthly health insurance surcharge for employees who don’t take the vaccines. The airline’s moves come amid growing pressure on companies to mandate vaccines for employees, particularly now that the Food and […]

Read More